Health Care & Life Sciences » Biotechnology | Jiangxi Boya Bio-Pharmaceutical Co. Ltd.

Jiangxi Boya Bio-Pharmaceutical Co. Ltd.

Jiangxi Boya Bio-Pharmaceutical Co. Ltd.
Stock Exchange Shenzhen Stock Exchange
EPS
CNY1.13
Market Cap
CNY11.56 B
Shares Outstanding
433.32 M
Public Float
160.32 M

Profile

Address
333 Huiquan Road
Fuzhou Jiangxi 344000
China
Employees -
Website http://www.china-boya.com
Updated 07/08/2019
Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. It operates through the following business segments: Blood Products, Diabetes Medication, and Biochemical drugs. The Blood Products segment includes products such as albumin, immunoglobulin, and blood clotting factors.

Financials

View All
Created with Highcharts 5.0.14Jiangxi Boya Bio-Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values CNY Millions.82821041041521522722723573574694692013201420152016201720180100200300400500
Created with Highcharts 5.0.14Jiangxi Boya Bio-Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values CNY Millions.2432434344345395399369361 4431 4432 4282 428201320142015201620172018050010001500200025003000

Ping Kai Ou Yang
Chairman-Supervisory Board
Xin Xi Liao
Chairman